Fed. Circ. Backs IP Extension For Photocure's Metvixia
The Metvixia patent will now expire in 2018 rather than 2016, the U.S. Court of Appeals for the Federal Circuit ruled Monday.
The extension was granted based on a provision in the patent statute that provides entities with an extended patent term when they are delayed in marketing their inventions by the regulatory approval process.
“The statute was...
To view the full article, register now.